Cronos Group (TSE:CRON) Stock Price Up 4.6% – Should You Buy?

Cronos Group Inc. (TSE:CRON)’s stock price traded up 4.6% on Monday . The stock traded as high as C$4.52 and last traded at C$4.52. Approximately 111,264 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 169,367 shares. The stock had previously closed at C$4.32.

Analyst Ratings Changes

Separately, TD increased their price objective on Cronos Group from C$5.50 to C$6.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of C$4.92.

Cronos Group Stock Up 4.6%

The company has a debt-to-equity ratio of 0.12, a current ratio of 16.18 and a quick ratio of 24.01. The stock has a 50 day simple moving average of C$4.25 and a 200-day simple moving average of C$3.88. The firm has a market cap of C$1.67 billion, a PE ratio of 23.79, a PEG ratio of 0.12 and a beta of 1.30.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.